NJ State Employees Deferred Compensation Plan’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,400	Closed	-$736K	–	508
2020 Q3	$736K	Hold	5,400	–	–	0.13%	156
2020 Q2	$522K	Hold	5,400	–	–	0.1%	207
2020 Q1	$253K	Hold	5,400	–	–	0.06%	324
2019 Q4	$394K	Buy	5,400 +1,400	+35%	+$84.9K	0.07%	331
2019 Q3	$209K	Buy	+4,000	New	+$213K	0.04%	468

NJ State Employees Deferred Compensation Plan's MYOK Position: Q4 2020 in Review

NJ State Employees Deferred Compensation Plan sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 5,400 shares — an estimated $736K sold.

NJ State Employees Deferred Compensation Plan first reported a position in MYOK in Q3 2019 and held it in 5 quarters. The position peaked at $736K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

NJ State Employees Deferred Compensation Plan reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 5,400 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $736K.
NJ State Employees Deferred Compensation Plan first reported a position in MyoKardia, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
NJ State Employees Deferred Compensation Plan's MyoKardia, Inc. Common Stock position peaked at $736K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q4 2020, filed 2 Feb 2021.